Fny Investment Advisers, LLC Synthetic Biologics, Inc. Transaction History

Fny Investment Advisers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 24, 2019	SELL	$4.9 - $6.6 $34,300 - $46,200	-7,000 Closed	0 $0
Q1 2019 Apr 17, 2019	BUY	$5.9 - $8.1 $28,591 - $39,252	4,846 Added 224.98%	7,000 $4,000
Q3 2018 Oct 29, 2018	BUY	$20.4 - $80.5 $43,941 - $173,397	2,154 New	2,154 $5,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.